0001104659-22-063025.txt : 20220519
0001104659-22-063025.hdr.sgml : 20220519
20220519204755
ACCESSION NUMBER: 0001104659-22-063025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220512
FILED AS OF DATE: 20220519
DATE AS OF CHANGE: 20220519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DST Capital LLC
CENTRAL INDEX KEY: 0001727656
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35853
FILM NUMBER: 22945029
BUSINESS ADDRESS:
STREET 1: C/O BIOSTAGE, INC.
STREET 2: 84 OCTOBER HILL ROAD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: 774-233-7300
MAIL ADDRESS:
STREET 1: C/O BIOSTAGE, INC.
STREET 2: 84 OCTOBER HILL ROAD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biostage, Inc.
CENTRAL INDEX KEY: 0001563665
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 455210462
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
STREET 2: SUITE 11
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: (774) 233-7300
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
STREET 2: SUITE 11
CITY: HOLLISTON
STATE: MA
ZIP: 01746
FORMER COMPANY:
FORMER CONFORMED NAME: Harvard Apparatus Regenerative Technology, Inc.
DATE OF NAME CHANGE: 20121204
4
1
tm2216158-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-05-12
0
0001563665
Biostage, Inc.
BSTG
0001727656
DST Capital LLC
C/O BIOSTAGE, INC.
84 OCTOBER HILL ROAD, SUITE 11
HOLLISTON
MA
01746
0
0
1
0
Common Stock
2022-05-12
4
P
0
8277
5.92
A
3658277
D
Common Stock
30722
I
Owned by sole member of reporting person
Warrants (right to buy)
8.88
2022-05-12
4
P
0
4139
A
2022-05-12
2027-05-12
Common Stock
4139
4139
D
On May 12, 2022, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 8,277 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 4,139 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $49,000.
This form has been signed under power of attorney.
/s/ Chad Porter, by power of attorney
2022-05-19